• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PNV
Click for more information
0.75% $2.03

POLYNOVO LIMITED - Charts / Financials

Market Cap $1.421B  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Instruments & Supplies

PolyNovo Limited is an Australia-based company, which is engaged in the development of... PolyNovo Limited is an Australia-based company, which is engaged in the development of medical devices for various medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM product is designed to help surgeons treat traumatic wounds. NovoSorb BTM may be used to temporarily close the wound and aid the body in generating new tissue. It is indicated for full or deep partial-thickness burns, surgical and reconstructive wounds and traumatic wounds. BTM is applied to a wound once the unhealthy or dead tissue has been surgically removed. NovoSorb is a medical-grade polymers that can be expressed in a range of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products.More

refresh Created with Sketch. REFRESH
Last update - 15.36pm 02/05/2024 (20 minute delay) ?
Day
Open $2.03   Day High $2.08   Day Low $2.02
Daily Volume 609238
Bids   Sellers
Number Price Volume   Number Price Volume
27 $2.02 68946   17 $2.03 13971

Directors & Senior Management

Mr. Swami Raote Chief Executive Officer
Mr. Jan Gielen Chief Financial Officer, Company Secretary
Dr. David McQuillan Chief Technical and Scientific Officer
Mr. Philip Scorgie Chief Information Officer
Mr. David John Williams Non-Executive Independent Chairman of the Board
Dr. Robyn Elliott Non-Executive Director
Ms. Christine Emmanuel-Donnelly Non-Executive Director
Mr. Leon Hoare Non-Executive Director
Mr. Andrew Stuart Lumsden Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
$2.03 		Change
0.015(0.75%) 		Mkt cap ! $1.421B
Open High Low Value Volume
$2.03 $2.08 $2.02 $1.249M 609.2K

Buyers (Bids)

No. Vol. Price($)
27 68946 $2.02
 

Sellers (Offers)

Price($) Vol. No.
$2.03 13971 17
View Market Depth
Last trade - 15.18pm 02/05/2024 (20 minute delay) ?
Last
$2.02 		  Change
0.015 ( 0.10 %)
Open High Low Volume
$2.03 $2.08 $2.02 348329
Last updated 15.36pm 02/05/2024 ?

Top Stories

Recharged Prospects: 'Watts' on the horizon for copper & lithium

The conversation goes much deeper that this title suggests - it explores everything from projections on aluminium & manganese, to what a Donald Trump government could mean for commodities markets.
Provident Aurum's off-market bid sends Sihayo shares soaring Small-cap mineral and gold explorer, Sihayo Gold (ASX:SIH) shares have soared, on news that the company has received intentions from Provident Aurum Pte to make an off-market takeover offer to acquire all shares of Sihayo Gold.
Lithium Universe ends the quarter charged up for Quebec Refinery roll-out Lithium Universe has closed off the March quarter with a new Chief Financial Officer and strategically located land anchored for its lithium refinery in Quebec, Canada.
Carnarvon revs up for revised Dorado Development The Dorado discovery appears on again, with Carnarvon Energy announcing the JV completing a revision of the project’s design to optimise capital costs and accelerate FID by the end of 2024.
Why Princeton Professor rates BlinkLab's autism & ADHD screening app In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.